Kanahara, Nobuhisa
Yamanaka, Hiroshi
Suzuki, Tomotaka
Takase, Masayuki
Iyo, Masaomi
Article History
Received: 15 May 2018
Accepted: 16 August 2018
First Online: 3 September 2018
Ethics approval and consent to participate
: The present study was approved by the ethics committees of the Chiba University Graduate School of Medicine (Chiba), Chiba Psychiatric Medical Center (Chiba), and Koutoku-kai Sato Hospital (Yamagata). Written informed consent to participate in the study was obtained from each patient or his/her guardian.
: Not applicable.
: Dr. Kanahara reports honoraria from Otsuka, Dainippon Sumitomo, Janssen and Meiji Seika Pharma. Dr. Takase reports honoraria from Otsuka and received grant support from SENSHIN Medical Research Foundation. Dr. Iyo received consultant fees from Janssen, Eli Lilly, Otsuka, Meiji Seika Pharma and reports honoraria from Janssen, Eli Lilly, Otsuka, Meiji Seika Pharma, Astellas, Dainippon Sumitomo, Ono, Mochida, MSD, Eisai, Daiichi-Sankyo, Novartis, Teijin, Shionogi, Hisamitsu and Asahi Kasei. Dr. Yamanaka and Dr. Suzuki declare no conflicts of interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.